Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BLI 1401

Next Previous
Search
Drug Profile

BLI 1401

Alternative Names: ABV 1501; ABV 1702; ABV 1703; ABV-1519; BLEX-404; BLI 1301; BLI-1401; BLI-1401-2

Latest Information Update: 28 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BioLite Inc
  • Developer ABVC BioPharma; BioLite Inc; Cedars-Sinai Medical Center; Taipei Veterans General Hospital
  • Class Antineoplastics; Beta Glucans
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Triple negative breast cancer
  • Preclinical Non-small cell lung cancer
  • No development reported Chronic lymphocytic leukaemia; Myelodysplastic syndromes; Pancreatic cancer

Most Recent Events

  • 28 Aug 2024 No recent reports of development identified for clinical-Phase-Unknown development in Myelodysplastic-syndromes in USA (PO, Liquid)
  • 28 Aug 2024 No recent reports of development identified for preclinical development in Pancreatic-cancer in USA (PO, Liquid)
  • 17 Apr 2024 ABVC Biopharma and its affiliate Rgene Corporation enters into a licensing agreement with OncoX for BLI 1401 for the treatment of non-small cell lung cancer

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top